Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1104909.RAU3v2Q0sqLVW1S7B70escf1rKxrmMwVQ5aXCN54GFCFM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1104909.RAU3v2Q0sqLVW1S7B70escf1rKxrmMwVQ5aXCN54GFCFM130_assertion type Assertion NP1104909.RAU3v2Q0sqLVW1S7B70escf1rKxrmMwVQ5aXCN54GFCFM130_head.
- NP1104909.RAU3v2Q0sqLVW1S7B70escf1rKxrmMwVQ5aXCN54GFCFM130_assertion description "[Overall, these data point to COX-2 inhibition as a potential strategy to be pursued with the aim at circumventing leukaemia-induced, IDO-mediated immune dysfunction.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1104909.RAU3v2Q0sqLVW1S7B70escf1rKxrmMwVQ5aXCN54GFCFM130_provenance.
- NP1104909.RAU3v2Q0sqLVW1S7B70escf1rKxrmMwVQ5aXCN54GFCFM130_assertion evidence source_evidence_literature NP1104909.RAU3v2Q0sqLVW1S7B70escf1rKxrmMwVQ5aXCN54GFCFM130_provenance.
- NP1104909.RAU3v2Q0sqLVW1S7B70escf1rKxrmMwVQ5aXCN54GFCFM130_assertion SIO_000772 23973990 NP1104909.RAU3v2Q0sqLVW1S7B70escf1rKxrmMwVQ5aXCN54GFCFM130_provenance.
- NP1104909.RAU3v2Q0sqLVW1S7B70escf1rKxrmMwVQ5aXCN54GFCFM130_assertion wasDerivedFrom befree-2016 NP1104909.RAU3v2Q0sqLVW1S7B70escf1rKxrmMwVQ5aXCN54GFCFM130_provenance.
- NP1104909.RAU3v2Q0sqLVW1S7B70escf1rKxrmMwVQ5aXCN54GFCFM130_assertion wasGeneratedBy ECO_0000203 NP1104909.RAU3v2Q0sqLVW1S7B70escf1rKxrmMwVQ5aXCN54GFCFM130_provenance.